首页> 外文期刊>American Journal of Management Science and Engineering >Management Experience in Fighting with COVID-19 and Other Aspects of Counteraction
【24h】

Management Experience in Fighting with COVID-19 and Other Aspects of Counteraction

机译:与Covid-19战斗的管理经验和抵制的其他方面

获取原文
       

摘要

Testing is central, early detection of the virus minimizes its further spread and allows rapid treatment of the sick - said the head of the South Korean Ministry of Foreign Affairs Kang Gyung Hua. He believes effective management and tests are key to our very low mortality rate. South Korea's health and public administration system was able to quickly protect the population from COVID-19 without the imposition of emergency measures. The adviser to the Swedish government and the Secretary-General of the World Health Organization, Yuhan Gizeke, told the RBC in an interview on May 5, 2020 that the authorities of the country relied on two measures in the fight against coronavirus whose benefit has scientific justification. First, we need to wash our hands, which we've known for 150 years. Second, social distance should be respected, that is, not to get too close to other people. Until May 5, 2020, Sweden recorded only 23216 cases of coronavirus infection. Developed countries have begun to develop a vaccine to combat COVID-19. Any vaccine contains a specific antigen - a protein that provokes antibody production - immune response. In the body antigen is met with specially adapted cells - macrophages. They get acquainted with the antigen and read information from it, - explains Alimbarov. - The obtained information they transmit to T lymphocytes, which in turn begin to change, and among them appear cells that will also participate in the immune process. T cells transmit information to B lymphocytes, which are converted into plasma cells capable of producing antibodies. Part of B lymphocytes is converted into memory cells. They store information about the antigen and, upon repeated encounter with a similar antigen, trigger an immune response (antibody formation) in a shorter time frame. The vaccine can be live (weakened virus), inactivated (dead virus) or vector - that's what the coronavirus vaccine will be. It contains a human-harmless adenovirus whose DNA contains the coronavirus gene. The adenovirus is then used as a delivery container.
机译:试验是中央,早期检测病毒可最大限度地减少其进一步的传播,并允许快速治疗生病 - 表示韩国外交部的负责人康戈元华。他认为,有效的管理和测试是我们的低死亡率的关键。韩国的健康和公共行政制度能够在没有紧急措施的情况下快速保护人口从Covid-19免受Covid-19。瑞典政府顾问和世界卫生组织秘书长玉汉格兹大道在2020年5月5日在采访中告诉了RBC,该国当局依靠两项措施对抗冠状病毒的斗争,其福利科学理由。首先,我们需要洗手,我们已经知道了150年。其次,应该尊重社会距离,即,不要太接近别人。直到2020年5月5日,瑞典只记录了冠状病毒感染的23216例。发达国家已经开始开发疫苗来打击Covid-19。任何疫苗含有特定的抗原 - 一种引发抗体生产 - 免疫应答的蛋白质。在体内抗原与特殊适应的细胞 - 巨噬细胞满足。他们熟悉抗原并从中阅读信息, - 解释Alimbarov。 - 所获得的信息,它们传递给T淋巴细胞,这反过来开始改变,其中包括将参与免疫过程的细胞。 T细胞将信息传递给B淋巴细胞,其转化为能够产生抗体的血浆细胞。 B淋巴细胞的一部分被转化为记忆细胞。它们存储有关抗原的信息,并且在重复遇到与类似的抗原反复遇到时,在较短的时间内触发免疫应答(抗体形成)。疫苗可以是活体(弱化病毒),灭活(死亡病毒)或载体 - 这就是冠状病毒疫苗的疫苗。它含有一种人无害的腺病毒,其DNA含有冠状病毒基因。然后使用腺病毒作为输送容器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号